1. Home
  2. FF vs CRBU Comparison

FF vs CRBU Comparison

Compare FF & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FutureFuel Corp.

FF

FutureFuel Corp.

HOLD

Current Price

$4.33

Market Cap

212.3M

Sector

Industrials

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$2.34

Market Cap

192.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FF
CRBU
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.3M
192.4M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
FF
CRBU
Price
$4.33
$2.34
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
303.8K
1.7M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
5.32%
N/A
EPS Growth
N/A
3.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.63
Revenue Next Year
N/A
$10.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$1.02
52 Week High
$5.12
$3.53

Technical Indicators

Market Signals
Indicator
FF
CRBU
Relative Strength Index (RSI) 53.28 62.14
Support Level $3.84 $1.75
Resistance Level $4.45 $2.97
Average True Range (ATR) 0.17 0.17
MACD -0.00 0.04
Stochastic Oscillator 93.33 73.77

Price Performance

Historical Comparison
FF
CRBU

About FF FutureFuel Corp.

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuels segment sells biodiesel and other petroleum products, with fuels made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment, which generates the majority of revenue, sells products used in the production of agricultural chemicals, including herbicides, as well as coatings and cleaning products such as detergents.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: